Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaid Haddad

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biomedical Research and Clinical Practice|September 11, 2020
Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assayNeil N Trivedi, Mehrdad Arjomandi, James K Brown, et al.
The Journal of Urology|August 30, 2016
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic PotentialEric A Klein, María Santiago-Jiménez, Kasra Yousefi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2015
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic AdenocarcinomasHarrison Tsai, Carlos L Morais, Mohammed Alshalalfa, et al.
Plos One|July 5, 2013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyNicholas Erho, Anamaria Crisan, Ismael A Vergara, et al.
European Urology|May 13, 2015
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypesScott A Tomlins, Mohammed Alshalalfa, Elai Davicioni, et al.
The Journal of Urology|June 18, 2013
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient populationR Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic DiseaseDaniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
European Urology|May 23, 2017
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy SpecimensPaul L Nguyen, Zaid Haddad, Ashley E Ross, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biomedical Research and Clinical Practice|September 11, 2020
Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assayNeil N Trivedi, Mehrdad Arjomandi, James K Brown, et al.
The Journal of Urology|August 30, 2016
Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic PotentialEric A Klein, María Santiago-Jiménez, Kasra Yousefi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2015
Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic AdenocarcinomasHarrison Tsai, Carlos L Morais, Mohammed Alshalalfa, et al.
Plos One|July 5, 2013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyNicholas Erho, Anamaria Crisan, Ismael A Vergara, et al.
European Urology|May 13, 2015
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypesScott A Tomlins, Mohammed Alshalalfa, Elai Davicioni, et al.
The Journal of Urology|June 18, 2013
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient populationR Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2017
Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic DiseaseDaniel E Spratt, Kasra Yousefi, Samineh Deheshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
European Urology|May 23, 2017
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy SpecimensPaul L Nguyen, Zaid Haddad, Ashley E Ross, et al.
European Urology|December 14, 2017
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence PostprostatectomyDaniel E Spratt, Darlene L Y Dai, Robert B Den, et al.
Pageof 3